Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mymd Pharmaceuticals Inc (NQ: MYMD )

1.800 -0.020 (-1.10%)
Streaming Delayed Price Updated: 9:57 AM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,045
Open 1.790
Bid (Size) 1.800 (40)
Ask (Size) 1.830 (2)
Prev. Close 1.820
Today's Range 1.790 - 1.840
52wk Range 1.750 - 63.90
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.
From MyMD Pharmaceuticals, Inc.
Via Business Wire
MYMD Stock Earnings: MyMD Pharmaceuticals Reported Results for Q1 2024
MyMD Pharmaceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-76.00%
-76.00%
1 Month
-3.23%
-3.23%
3 Month
-30.23%
-30.23%
6 Month
-67.78%
-67.78%
1 Year
-94.34%
-94.34%

More News

Read More
Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
From MyMD Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
Via AB Newswire
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
MyMD Pharmaceuticals Secures Strategic Investments
From MyMD Pharmaceuticals, Inc.
Via Business Wire
MYMD Stock Earnings: MyMD Pharmaceuticals Reported Results for Q4 2023
Via InvestorPlace
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?
Via InvestorPlace
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?
Via InvestorPlace
Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
From MyMD Pharmaceuticals, Inc.
Via Business Wire
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
From MyMD Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.